Archive for November 17th, 2009

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against CVS Caremark Corporation (Business Wire)

NEW YORK—-Coughlin Stoia Geller Rudman & Robbins LLP today announced that a class action has been commenced in the United States District Court for the District of Rhode Island on behalf of purchasers of CVS Caremark Corporation common stock during the period between May 5, 2009 and November 4, 2009, inclusive , for violations of the Securities Exchange Act of 1934 .

No Comments

Autodesk posts lower 3Q profit, sales, shares fall (AP)

Design and engineering software maker Autodesk Inc. said Tuesday its business looks “increasingly stable” despite posting a sharp drop in third-quarter profit.

No Comments

Business Highlights (AP)

A decline in factory production in October signals that consumers and businesses remain cautious in their spending, with the economic recovery likely to be sluggish.

No Comments

Wall St gains on broker views, but retailers sink (Reuters)

U.S. stocks rose to fresh 13-month highs on Tuesday as upbeat broker views on improving prospects for two Dow components offset disappointing holiday spending outlooks from Target and Home Depot.

No Comments

Saks, Home Depot, Applied Materials are big movers (AP)

The following stocks were among those that moved substantially or traded heavily Tuesday on the New York Stock Exchange:

No Comments

TradingMarkets 7 ETFs You Need to Know for Wednesday (TradingMarkets.com)

Equity index exchange-traded funds such as the Dow DIAMONDS ETF, DIA and the iShares Russell 2000 Index ETF, IWM fought off early selling to close near breakeven levels.

No Comments

NeurogesX shares rise following FDA approval (AP)

Shares of biotechnology company NeurogesX Inc. jumped Tuesday after the company received Food and Drug Administration approval for its Qutenza pain patch.

No Comments

InterMune shares fall on change in hepatitis study (AP)

Shares of InterMune Inc. fell Tuesday after the biotechnology company said it would discontinue a high-dose of its experimental Hepatitis C treatment in a study because of potential liver damage.

No Comments

Target holiday results may disappoint, shares fall (Reuters)

Discount retailer Target Corp reported third-quarter results that beat Wall Street expectations but forecast a holiday quarter profit that could fall short of estimates, and its shares fell over 5 percent.

No Comments

Assured Guaranty 3Q loss narrows, shares soar (AP)

Shares of Assured Guaranty Ltd. soared Tuesday, a day after the bond insurer posted a narrower third-quarter loss. Operating improvements partly offset higher losses from mortgage-backed securities during the quarter, the company said.

No Comments